ImmunoGen (IMGN) P/FCF US GAAP (year values) |
||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
| P/FCF | -3.91 | -8.31 | -14.3 | -8.14 | -5.44 | -12.1 | ||
| Changes by years, y/y, % | -104% | +112% | +72% | -43% | -33% | |||
ImmunoGen. P/FCF
ImmunoGen. P/FCF, changes, %
ImmunoGen (IMGN) P/FCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| P/FCF | -14.2 | -17.7 | -74.4 | -32.8 | -12.1 | |||
| Changes by years, y/y, % | +157% | +245% | +1 269% | -100% | +494% | |||
| Changes by quarters, q/q, % | +290% | +24% | +321% | -100% | ||||